Haemonetics (HAE) Share-based Compensation Growth (5y) (2014 - 2026)
Haemonetics (HAE) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Haemonetics | 3.79 Bn | 3.55 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -63.51% |
| Dec 27, 2025 | -52.01% |
| Sep 27, 2025 | -22.50% |
| Jun 28, 2025 | 8.59% |
| Mar 29, 2025 | -33.92% |
| Dec 28, 2024 | 9.06% |
| Sep 28, 2024 | -1.08% |
| Jun 29, 2024 | 15.57% |
| Dec 30, 2023 | -61.03% |
| Sep 30, 2023 | -17.61% |
| Jul 1, 2023 | 15.64% |
| Apr 1, 2023 | -39.43% |
| Dec 31, 2022 | 18.83% |
| Oct 1, 2022 | 31.04% |
| Apr 2, 2022 | -57.13% |
| Jan 1, 2022 | 22.16% |
| Oct 2, 2021 | 20.08% |
| Jul 3, 2021 | 29.99% |
| Apr 3, 2021 | 56.81% |
| Dec 26, 2020 | 22.11% |